Uniphar plc (LON:UPR - Get Free Report)'s stock price traded down 2.4% on Tuesday . The company traded as low as GBX 182.18 ($2.34) and last traded at GBX 183.50 ($2.36). 8,571 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 37,913 shares. The stock had previously closed at GBX 188 ($2.42).
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 310 ($3.99) price objective on shares of Uniphar in a research note on Wednesday, September 4th.
Check Out Our Latest Analysis on Uniphar
Uniphar Price Performance
The firm has a market capitalization of £485.98 million, a P/E ratio of 1,321.43 and a beta of 0.75. The company has a debt-to-equity ratio of 119.43, a current ratio of 0.90 and a quick ratio of 0.60. The stock's fifty day simple moving average is GBX 209.45 and its 200 day simple moving average is GBX 214.88.
Uniphar Cuts Dividend
The company also recently announced a dividend, which was paid on Friday, October 4th. Shareholders of record on Thursday, September 12th were issued a €0.01 ($0.01) dividend. The ex-dividend date was Thursday, September 12th. This represents a yield of 0.25%. Uniphar's dividend payout ratio is presently 1,428.57%.
About Uniphar
(
Get Free Report)
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.
Featured Articles
Before you consider Uniphar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uniphar wasn't on the list.
While Uniphar currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
